Tuesday, October 13, 2015
1012 C Street  •  Floresville, TX 78114  •  Phone: 830-216-4519  •  Fax: 830-393-3219  • 

WCN Site Search

Lost & Found

Missing: Male Chihuahua, black/gray/white, named Spy, possibly missing from F.M. 775 around Vintage Oaks Subdivision and Woodlands area, Sat., Sept. 26 about 10 p.m. 830-391-5055. 
Lost: Chihuahua, black, tan, and white male, "Spy," very small, off F.M. 775, across from the Woodlands on Sept. 26, he is missed dearly. Call 830-391-5055.
Found: Young male Black Lab, first week in October, wearing orange collar, friendly, on C.R. 158 off F.M. 2579. Call Jeanette at 830-391-4036 to claim.
More Lost & Found ads ›

Help Wanted

Accepting applications at Wilson County News for part-time office help. Must have great customer service skills, computer literate, experience with Adobe, PhotoShop, and Adobe InDesign (or QuarkXpress) preferred. Send resume to olga@wcn-online.com.
Sign maker/installer, no experience necessary, will train. Must have reliable transportation, valid driver license, must be able to work indoors/outdoors. Apply in person at Photographs by Jim, Eagle Ford signs, 1013 C St., Floresville. NO PHONE CALLS.
More Help Wanted ads ›

Featured Videos

Video Vault ›
WCN Citizens Forum 5/28/15WCN essential oilsWCN printing

Breaking News

Ritedose recalls mislabeled Albuterol

E-Mail this Story to a Friend
Print this Story
U.S. Food and Drug Administration
January 3, 2011, 4:36pm
1,974 views | Post a comment

The Ritedose Corporation is conducting a voluntary recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL (in 25, 30, and 60 unit dose vials). This product is a prescription inhalation solution, administered via nebulization, for the treatment and maintenance of acute asthma exacerbations and exercise induced asthma in children and adults. This product is being recalled because the 2.5 mg/3 mL single use vials are embossed with the wrong concentration of 0.5 mg/ 3 mL and therefore, represents a potential significant health hazard. The following lot numbers manufactured by The Ritedose Corporation under NDC: 0591-3797-83, 0591-3797-30, and 0591-3797-60 are included in the recall: 0N81, 0N82, 0N83, 0N84, 0NE7, 0NE8, 0NE9, 0NF0, 0P12, 0P13, 0P46, 0P47, 0PF0, and 0S15. No other Albuterol formulations or products are included in this recall.

The product is packaged as a single use unit dose vials in a protective foil overwrap packaged in a shelf carton. Only the unit dose vials are incorrectly embossed as containing 0.5 mg/3 mL. The correct concentration of 2.5 mg/3 mL is labeled on the primary foil overwrap pouches and shelf cartons. This product was distributed nationwide and Puerto Rico.

Administration of this defective product could result in a range of potential health effects that spans from temporary and medically reversible to life threatening and death. There is significant concern that health professionals who read the incorrect embossed concentration may upwardly adjust the volume of product used resulting in an administered amount that is 5 times the recommended dose. In the hospital setting, the vials are often not accompanied by the rest of the packaging, making it more likely that such a dosing error could occur. Significant overdosing of a patient could lead to signs and symptoms of albuterol toxicity, which includes tremors, dizziness, nervousness, headache, seizures, angina, high blood pressure, low potassium levels, and rapid heart rates up to 200 beats/minute.

The Ritedose Corporation is working cooperatively with the U.S. FDA to implement a nationwide recall as quickly and efficiently as possible.

Consumers should immediately return the affected product to the place it was obtained (i.e. doctor’s office, pharmacy, etc.). Wholesalers and retailers should return the product to the following address:

Total Product Destruction
8025 Howard Street
Spartanburg, SC 29303

For more information concerning this recall contact The Ritedose Corporation directly at phone: 803-935-3995 Monday through Friday 8am to 5 pm EST or by e-mail: recall@ritedose.com.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program online, or regular mail or by fax.

Your Opinions and Comments

Be the first to comment on this story!

You must be logged in to post a comment.

Not a subscriber?
Subscriber, but no password?
Forgot password?

Breaking News Archives

Connally Memorial MC breaking news banner
Malcolm's Custom Welding
Southern Electric
Drama KidsVoncille Bielefeld homeAllstate & McBride Realtyauto chooserHeavenly Touch homeTriple R DC Experts

  Copyright © 2007-2015 Wilson County News. All rights reserved. Web development by Drewa Designs.